These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1316944)

  • 1. T cell responses to the human papillomavirus type 16 E7 protein in mice of different haplotypes.
    Shepherd PS; Tran TT; Rowe AJ; Cridland JC; Comerford SA; Chapman MG; Rayfield LS
    J Gen Virol; 1992 May; 73 ( Pt 5)():1269-74. PubMed ID: 1316944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization and immunotherapy for cancers involving infection by a human papillomavirus in a mouse model.
    Li J; Sun Y; Garen A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16232-6. PubMed ID: 12446839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice.
    Tindle RW; Herd K; Londoño P; Fernando GJ; Chatfield SN; Malcolm K; Dougan G
    Virology; 1994 May; 200(2):547-57. PubMed ID: 7513919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profile of draining lymph node lymphocytes in mice grafted with syngeneic keratinocytes expressing human papillomavirus type 16 E7 protein.
    López MC; Stanley MA
    J Gen Virol; 2000 May; 81(Pt 5):1175-82. PubMed ID: 10769058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type 16 E7 peptide(38-61) linked with an immunoglobulin G fragment provides protective immunity in mice.
    Qin Y; Wang XH; Cui HL; Cheung YK; Hu MH; Zhu SG; Xie Y
    Gynecol Oncol; 2005 Feb; 96(2):475-83. PubMed ID: 15661238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness.
    Chambers MA; Wei Z; Coleman N; Nash AA; Stanley MA
    Eur J Immunol; 1994 Mar; 24(3):738-45. PubMed ID: 8125141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.
    Michel N; Osen W; Gissmann L; Schumacher TN; Zentgraf H; Müller M
    Virology; 2002 Mar; 294(1):47-59. PubMed ID: 11886264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific.
    Kadish AS; Romney SL; Ledwidge R; Tindle R; Fernando GJ; Zee SY; Van Ranst MA; Burk RD
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2277-84. PubMed ID: 8077925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame protein.
    Selvey LA; Tindle RW; Geysen HM; Haller CJ; Smith JA; Frazer IH
    J Immunol; 1990 Nov; 145(9):3105-10. PubMed ID: 1698872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
    Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
    Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.
    Kim TY; Myoung HJ; Kim JH; Moon IS; Kim TG; Ahn WS; Sin JI
    Cancer Res; 2002 Dec; 62(24):7234-40. PubMed ID: 12499264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells.
    Murakami M; Gurski KJ; Marincola FM; Ackland J; Steller MA
    Cancer Res; 1999 Mar; 59(6):1184-7. PubMed ID: 10096544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein.
    Herd K; Fernando GJ; Dunn LA; Frazer IH; Lambert P; Tindle RW
    Virology; 1997 Apr; 231(1):155-65. PubMed ID: 9143315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.
    Feltkamp MC; Smits HL; Vierboom MP; Minnaar RP; de Jongh BM; Drijfhout JW; ter Schegget J; Melief CJ; Kast WM
    Eur J Immunol; 1993 Sep; 23(9):2242-9. PubMed ID: 7690326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-helper epitopes of the E7 transforming protein of cervical cancer associated human papillomavirus type 18 (HPV18).
    Fernando GJ; Tindle RW; Frazer IH
    Virus Res; 1995 Apr; 36(1):1-13. PubMed ID: 7542826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of an expression vector for human papillomavirus type 16 E7-glutathione S transferase fusion protein.
    Chinami M; Shingu M
    Kurume Med J; 1992; 39(1):9-12. PubMed ID: 1320148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16.
    Comerford SA; McCance DJ; Dougan G; Tite JP
    J Virol; 1991 Sep; 65(9):4681-90. PubMed ID: 1714516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
    Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
    J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.